Shay Capital’s iShares Biotechnology ETF IBB Stock Holding History

Shay Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,000	Closed	-$274K	–	338
2024 Q1	$274K	Buy	+2,000	New	+$273K	0.04%	266
2022 Q2	–	Sell	-4,000	Closed	-$521K	–	518
2022 Q1	$521K	Buy	+4,000	New	+$521K	0.07%	236

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Shay Capital's IBB Position: Q2 2024 in Review

Shay Capital sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 2,000 shares — an estimated $274K sold.

Shay Capital first reported a position in IBB in Q1 2022 and held it in 2 quarters. The position peaked at $521K in Q1 2022. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

Shay Capital reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
Shay Capital sold 2,000 iShares Biotechnology ETF shares in Q2 2024, an estimated $274K.
Shay Capital first reported a position in iShares Biotechnology ETF in Q1 2022 and held it in 2 quarters.
Shay Capital's iShares Biotechnology ETF position peaked at $521K in Q1 2022.
894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Shay Capital's 13F filing for Q2 2024, filed 14 Aug 2024.